Related Experiment Video
Updated: Nov 27, 2025
08:36
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
905
The bigger, the better? When multicenter clinical trials and meta-analyses do not work
Soroush Seifirad1, Lance Alquran1
1Department of Medicine, Hackensack Meridian Health Mountainside Medical Center, Montclair, NJ, USA.
Current Medical Research and Opinion
|December 8, 2020
Summary
While large multicenter studies and meta-analyses offer high evidence levels, single-center studies can be crucial. This analysis explores scenarios where smaller studies may be preferred over larger ones for treatment efficacy.
Area of Science:
- Medical Research Methodology
- Evidence-Based Medicine
- Clinical Trials
Background:
- The rise of the internet and globalization has led to an increase in large-scale multicenter studies and meta-analyses.
- These large studies are considered powerful, revolutionizing modern medicine and drug development by providing high levels of evidence.
- However, discrepancies can arise where single or local center studies show treatment efficacy that larger studies fail to confirm, and vice versa.
Purpose of the Study:
- To explore specific scenarios where multicenter studies and meta-analyses may not be the optimal choice for evaluating treatment efficacy.
- To highlight the continued importance and potential advantages of single-center studies in certain research contexts.
- To provide a nuanced understanding of evidence hierarchy in medical research.
Main Methods:
- Discussion of three distinct scenarios illustrating the limitations of large-scale studies.
- Comparative analysis of evidence strength from single-center versus multicenter studies.
- Exploration of factors influencing treatment efficacy findings across different study scales.
Main Results:
- Identified specific circumstances where single-center studies provide more relevant or accurate efficacy data than larger, multicenter investigations.
- Demonstrated that larger study size does not always equate to superior or more applicable findings.
- Highlighted the potential for bias or confounding factors in large meta-analyses that may obscure true treatment effects observed in smaller cohorts.
Conclusions:
- Single-center studies retain significant value and can be preferable to multicenter studies or meta-analyses in particular situations.
- A critical appraisal of study design and context is necessary when interpreting treatment efficacy data.
- The hierarchy of evidence should be applied judiciously, considering the unique insights offered by diverse research methodologies.
Keywords:
Clinical trialbiostatisticsclinical decision makingmetanalysispersonalized medicinepublic healthresearch methodologyMore Related Videos
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
14.9K
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
11.0K
Related Concept Videos
01:16Clinical Trials
10.0K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.0K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
272
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
272
01:11Clinical Trials: Overview
4.3K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.3K
01:29Bias in Epidemiological Studies
1.0K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
1.0K
01:12Hazard Ratio
395
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
395
01:27Confounding in Epidemiological Studies
396
Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
396